SAKAR HEALTHCARE
Back to Income Statement
|
SAKAR HEALTHCARE Last 5 Year Total Expenditure History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Expenditure | ₹115 Cr | ₹100 Cr | ₹99 Cr | ₹72 Cr | ₹6,343,119 Cr |
What is the latest Total Expenditure of SAKAR HEALTHCARE ?
| Year | Total Expenditure |
|---|---|
| Mar2025 | ₹115 Cr |
| Mar2024 | ₹100 Cr |
| Mar2023 | ₹99 Cr |
| Mar2022 | ₹72 Cr |
| Mar2021 | ₹6,343,119 Cr |
How is Total Expenditure of SAKAR HEALTHCARE Trending?
| Years | Total Expenditure | % Change | |
|---|---|---|---|
| Mar2025 | ₹115 Cr | 14.86 | |
| Mar2024 | ₹100 Cr | 1.22 | |
| Mar2023 | ₹99 Cr | 37.10 | |
| Mar2022 | ₹72 Cr | -100.00 | |
| Mar2021 | ₹6,343,119 Cr | - | |
Compare Total Expenditure of peers of SAKAR HEALTHCARE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SAKAR HEALTHCARE | ₹1,102.3 Cr | 23% | 27.7% | 53.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹408,991.0 Cr | 0.1% | -3.2% | -2.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹162,371.0 Cr | -1.5% | -7.3% | 2.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,229.0 Cr | -1.3% | -0.7% | 24.4% | Stock Analytics | |
| CIPLA | ₹108,441.0 Cr | 1.5% | -8.1% | -6.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,407.0 Cr | 3.2% | 5.6% | 3.1% | Stock Analytics | |
SAKAR HEALTHCARE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SAKAR HEALTHCARE | 23% |
27.7% |
53.9% |
| SENSEX | 2.9% |
-1.1% |
8.5% |
You may also like the below Video Courses